|
Name |
Caspicaiene
|
| Molecular Formula | C27H34O9 | |
| IUPAC Name* |
(15-acetyloxy-13-hydroxy-9,9,14,16,19-pentamethyl-18-methylidene-4,10-dioxo-5,6-dioxapentacyclo[12.6.0.01,7.03,16.09,14]icos-11-en-8-yl)acetate
|
|
| SMILES |
C=C1CC23C4OOC(=O)C2C1(C)C(OC(C)=O)C(O)C3(C)C1(C)C=CC(=O)C(C)(C)C1C4OC(C)=O
|
|
| InChI |
InChI=1S/C27H34O9/c1-12-11-27-18-22(32)36-35-20(27)16(33-13(2)28)17-23(4,5)15(30)9-10-24(17,6)26(27,8)19(31)21(25(12,18)7)34-14(3)29/h9-10,16-21,31H,1,11H2,2-8H3/t16-,17?,18?,19?,20?,21+,24-,25?,26-,27?/m1/s1
|
|
| InChIKey |
KUVWFENIBLGCNF-APKODVJJSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 502.56 | ALogp: | 2.5 |
| HBD: | 1 | HBA: | 9 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 125.4 | Aromatic Rings: | 5 |
| Heavy Atoms: | 36 | QED Weighted: | 0.344 |
| Caco-2 Permeability: | -5.302 | MDCK Permeability: | 0.00002520 |
| Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.857 | 20% Bioavailability (F20%): | 0.943 |
| 30% Bioavailability (F30%): | 0.213 |
| Blood-Brain-Barrier Penetration (BBB): | 0.732 | Plasma Protein Binding (PPB): | 40.42% |
| Volume Distribution (VD): | 0.583 | Fu: | 56.66% |
| CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.121 |
| CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.706 |
| CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.057 |
| CYP2D6-inhibitor: | 0.04 | CYP2D6-substrate: | 0.069 |
| CYP3A4-inhibitor: | 0.612 | CYP3A4-substrate: | 0.475 |
| Clearance (CL): | 3.237 | Half-life (T1/2): | 0.036 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.118 |
| Drug-inuced Liver Injury (DILI): | 0.098 | AMES Toxicity: | 0.036 |
| Rat Oral Acute Toxicity: | 0.957 | Maximum Recommended Daily Dose: | 0.886 |
| Skin Sensitization: | 0.021 | Carcinogencity: | 0.397 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.024 |
| Respiratory Toxicity: | 0.959 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005316 | ![]() |
0.349 | D0H2MO | ![]() |
0.329 | ||
| ENC003179 | ![]() |
0.349 | D03ZZK | ![]() |
0.277 | ||
| ENC003159 | ![]() |
0.349 | D0G7KJ | ![]() |
0.270 | ||
| ENC004311 | ![]() |
0.344 | D0OL7F | ![]() |
0.260 | ||
| ENC003163 | ![]() |
0.322 | D09SIK | ![]() |
0.250 | ||
| ENC002259 | ![]() |
0.316 | D08BDT | ![]() |
0.245 | ||
| ENC006041 | ![]() |
0.314 | D09WYX | ![]() |
0.245 | ||
| ENC003776 | ![]() |
0.314 | D0E9KA | ![]() |
0.238 | ||
| ENC005315 | ![]() |
0.313 | D02QJH | ![]() |
0.231 | ||
| ENC005188 | ![]() |
0.308 | D01ZOG | ![]() |
0.231 | ||